Rab 32 inhibitors are a class of compounds that interact with Rab 32 or its associated pathways to modulate its activity within the cell. These inhibitors may exert their effects by directly targeting Rab 32 or by influencing the numerous cellular processes that Rab 32 is involved with. Due to the central role of Rab 32 in vesicular trafficking and membrane fusion, compounds that affect these cellular processes can, by extension, modulate the function of Rab 32. The inhibitory actions of these compounds encompass a broad range of mechanisms, from altering enzyme activities that participate in Rab 32 activation, such as tyrosine kinases and lipid kinases, to affecting the cytoskeletal dynamics and membrane trafficking machinery that Rab 32 is associated with.
The molecules that fall into the category of Rab 32 inhibitors display diverse chemical structures and properties, reflecting the various mechanisms by which they impact Rab 32 activity. These compounds are not uniform in their action but are unified by the outcome of their activity, which is the modulation of Rab 32 function. By interfering with upstream signaling pathways, these chemicals can alter the phosphorylation patterns of proteins related to Rab 32, change the lipid composition of membranes where Rab 32 operates, or modify the cytoskeletal elements that are necessary for Rab 32-mediated vesicular transport. Each chemical exhibits specificity in its mode of action, contributing to the collective ability to influence Rab 32 activity within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A phosphoinositide 3-kinase inhibitor that can disrupt signaling pathways influencing Rab 32-mediated vesicular trafficking. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
An HMG-CoA reductase inhibitor that affects cholesterol biosynthesis, potentially altering membrane composition and Rab 32 localization. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
A microtubule-stabilizing agent that can disrupt intracellular transport, indirectly affecting Rab 32-related processes. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
A microtubule-depolymerizing agent that can perturb Rab 32-associated vesicle transport. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
A Cdc42 inhibitor that may disrupt downstream effects of Rab 32 in cytoskeletal organization. | ||||||
PKF118-310 | 84-82-2 | sc-364590 sc-364590A | 5 mg 25 mg | $180.00 $651.00 | ||
A protein kinase inhibitor that could impair phosphorylation states of proteins interacting with Rab 32. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
An inhibitor of cytohesins, affecting ARF proteins and potentially altering Rab 32-related trafficking. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
An inhibitor of ADP-ribosylation factor (ARF), which could modulate Rab 32 activity by impacting vesicle formation. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
A protein kinase C inhibitor that can alter signaling cascades related to Rab 32's function. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
A GTPase inhibitor of dynamin that could affect endocytosis and vesicle trafficking involving Rab 32. | ||||||